Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Blood|October 10, 2015
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patientsXénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.
Blood|July 8, 2011
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitorsElodie Pronier, Carole Almire, Hayat Mokrani, et al.
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Nature Communications|November 28, 2017
Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defectKahia Messaoudi, Ashfaq Ali, Rameez Ishaq, et al.
Haematologica|March 6, 2025
Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndromeLarissa Lordier, Christian A Di Buduo, Alexandre Kauskot, et al.
Blood Cancer Journal|November 5, 2025
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with mastocytosis regressionJulie Bruneau, Sophie Georgin-Lavialle, Sophia Ladraa, et al.
The New England Journal of Medicine|May 29, 2009
Mutation in TET2 in myeloid cancersFrançois Delhommeau, Sabrina Dupont, Véronique Della Valle, et al.
Nature Communications|April 14, 2018
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosisMargaux Sevin, Lucia Kubovcakova, Nicolas Pernet, et al.
Blood Advances|February 22, 2024
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosisMarie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
The Journal of Clinical Investigation|May 19, 2022
Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia modelBrahim Arkoun, Elie Robert, Fabien Boudia, et al.
Pageof 16